Related Experiment Videos
Fatty liver and drugs.
A Grieco1, A Forgione, L Miele
1Department of Internal Medicine, Catholic University of the Sacred Hear, Rome, Italy.
European Review for Medical and Pharmacological Sciences
|October 22, 2005
Summary
Drug-induced liver diseases (DILD) are liver injuries from medications, with steatohepatitis being a rare form. Diagnosis relies on correlating patient history with clinical, lab, and histological findings.
Area of Science:
- Hepatology
- Toxicology
- Internal Medicine
Background:
- Drug-induced liver diseases (DILD) represent diverse clinico-pathologic liver injuries caused by exogenous compounds.
- Steatohepatitis is an uncommon manifestation of DILD, with drugs contributing minimally to non-alcoholic steatohepatitis (NASH).
Purpose of the Study:
- To categorize drugs causing steatosis and steatohepatitis.
- To outline the spectrum of clinical DILD syndromes.
- To emphasize diagnostic criteria for DILD.
Main Methods:
- Classification of drugs based on their capacity to induce steatosis/steatohepatitis.
- Review of clinical presentations of DILD.
- Highlighting the importance of correlating clinical data for diagnosis.
Main Results:
- Drugs inducing steatosis/steatohepatitis fall into three groups: independent inducers, precipitators of latent NASH, and sporadic inducers.
- Clinical syndromes of DILD are varied, including hepatitis-like injury, liver failure, cholestasis, and cirrhosis.
- The mechanism of injury does not dictate the clinical presentation.
Conclusions:
- Accurate diagnosis of DILD necessitates a comprehensive correlation of patient history with clinical, laboratory, and histological evidence.
- Understanding drug-induced liver injury mechanisms and presentations is crucial for patient management.